TY - BOOK
T1 - Prostaglandins in action. Indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions
AU - Wong, Siu Ling
AU - Wong, Wing Tak
AU - Tian, Xiao Yu
AU - Lau, Chi Wai
AU - Huang, Yu
PY - 2010/11/22
Y1 - 2010/11/22
N2 - Endothelium regulates local vascular tone by means of releasing relaxing and contracting factors, of which the latter have been found to be elevated in vascular pathogenesis of hypertension, diabetes, hypercholesterolemia, and aging. Endothelium-derived contracting factors (EDCFs) are mainly metabolites of arachidonic acid generated by cyclooxygenase (COX), as vasodilatations in patients with hypertension, metabolic diseases, or advancing age are improved by acute treatment with COX inhibitor indomethacin. COX is presented in two isoforms, COX-1 and COX-2, with the former regarded as constitutive and the latter mainly expressed upon induction. Experiments with animal models of vascular dysfunctions, however, reveal that both isoforms have similar capacity to participate in endothelium-dependent contractions, with augmented expression and activity. COX-derived prostaglandin (PG) H2, PGF2α, PGE2, prostacyclin (PGI2), and thromboxane A2 (TxA2) are the proposed EDCFs that mediate endothelium-dependent contractions via the activation of thromboxane-prostanoid (TP) receptor in various vascular beds from different species. Although COX inhibition seems to be a possible strategy in combating COX-associated vascular complications, the incidence of adverse cardiovascular effects of Vioxx has greatly antagonized this concept. Further review of COX inhibitors is required, especially toward the selectivity of coxibs and whether it directly inhibits prostacyclin synthase activity. Meanwhile, TP receptor antagonism may emerge as a therapeutic alternative to reverse prostanoid-mediated vascular dysregulations.
AB - Endothelium regulates local vascular tone by means of releasing relaxing and contracting factors, of which the latter have been found to be elevated in vascular pathogenesis of hypertension, diabetes, hypercholesterolemia, and aging. Endothelium-derived contracting factors (EDCFs) are mainly metabolites of arachidonic acid generated by cyclooxygenase (COX), as vasodilatations in patients with hypertension, metabolic diseases, or advancing age are improved by acute treatment with COX inhibitor indomethacin. COX is presented in two isoforms, COX-1 and COX-2, with the former regarded as constitutive and the latter mainly expressed upon induction. Experiments with animal models of vascular dysfunctions, however, reveal that both isoforms have similar capacity to participate in endothelium-dependent contractions, with augmented expression and activity. COX-derived prostaglandin (PG) H2, PGF2α, PGE2, prostacyclin (PGI2), and thromboxane A2 (TxA2) are the proposed EDCFs that mediate endothelium-dependent contractions via the activation of thromboxane-prostanoid (TP) receptor in various vascular beds from different species. Although COX inhibition seems to be a possible strategy in combating COX-associated vascular complications, the incidence of adverse cardiovascular effects of Vioxx has greatly antagonized this concept. Further review of COX inhibitors is required, especially toward the selectivity of coxibs and whether it directly inhibits prostacyclin synthase activity. Meanwhile, TP receptor antagonism may emerge as a therapeutic alternative to reverse prostanoid-mediated vascular dysregulations.
KW - Contractions
KW - Cyclooxygenase
KW - Endothelium
KW - Prostaglandin
KW - TP receptor
UR - http://www.scopus.com/inward/record.url?scp=78349266804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78349266804&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-385061-4.00003-9
DO - 10.1016/B978-0-12-385061-4.00003-9
M3 - Book
C2 - 21081215
AN - SCOPUS:78349266804
VL - 60
T3 - Advances in Pharmacology
BT - Prostaglandins in action. Indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions
PB - Elsevier
ER -